{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:05:44Z","timestamp":1790139944832,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Iberoamericana de Micolog\u00eda"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.riam.2026.06.004","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T15:16:28Z","timestamp":1787411788000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isavuconazole utilization in a Spanish tertiary hospital"],"prefix":"10.1016","author":[{"given":"Teresa","family":"L\u00f3pez-Cuesta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Mej\u00eda-Abril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Fern\u00e1ndez-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6519-8885","authenticated-orcid":false,"given":"Francisco","family":"Abad-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.riam.2026.06.004_bib0110","series-title":"Ficha t\u00e9cnica de isavuconazol [Internet]","year":"2016"},{"key":"10.1016\/j.riam.2026.06.004_bib0115","series-title":"Informe de Posicionamiento Terap\u00e9utico de isavuconazol (Cresemba\u00ae) en el tratamiento de la aspergilosis invasora y la mucormicosis versi\u00f3n 55\/2016 [Internet]","year":"2016"},{"key":"10.1016\/j.riam.2026.06.004_bib0120","first-page":"461","article-title":"Evaluaci\u00f3n de la causalidad en reacciones adversas a medicamentos: algoritmo del SEFV","volume":"32","author":"Aguirre","year":"2014","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.riam.2026.06.004_bib0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/myc.13189","article-title":"Cost-effectiveness of isavuconazole vs voriconazole in invasive mould disease in Spain","volume":"64","author":"Azanza","year":"2021","journal-title":"Mycoses"},{"issue":"Suppl. 2","key":"10.1016\/j.riam.2026.06.004_bib0130","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2026.06.004_bib0135","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/myc.12635","article-title":"Antifungal prophylaxis in AML: adherence to guidelines in real life","volume":"60","author":"Berking","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.riam.2026.06.004_bib0140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/jof9020241","article-title":"Antifungal activity of isavuconazole against Mucorales isolates from multiple regions","volume":"9","author":"Carvalhaes","year":"2023","journal-title":"J Fungi"},{"key":"10.1016\/j.riam.2026.06.004_bib0145","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.riam.2026.06.004_bib0150","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of EORTC\/MSG definitions of invasive fungal disease","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2026.06.004_bib0155","series-title":"Orphan designation: overview [Internet]","year":"2018"},{"key":"10.1016\/j.riam.2026.06.004_bib0160","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.eimc.2018.03.018","article-title":"Executive summary of clinical practice guideline for invasive Aspergillus disease (GEMICOMED-SEIMC\/REIPI, 2018 update)","volume":"37","author":"Garcia-Vidal","year":"2019","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.riam.2026.06.004_bib0165","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmi.2022.01.027","article-title":"COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis","volume":"28","author":"Kariyawasam","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.riam.2026.06.004_bib0170","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/cid\/ciy827","article-title":"Isavuconazole versus caspofungin for candidemia and invasive Candida infections (ACTIVE trial)","volume":"68","author":"Kullberg","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2026.06.004_bib0175","doi-asserted-by":"crossref","first-page":"e00177-22","DOI":"10.1128\/aac.00177-22","article-title":"New perspectives on antimicrobial agents: isavuconazole","volume":"66","author":"Lewis","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2026.06.004_bib0180","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease (SECURE): a phase 3 randomized-controlled non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.riam.2026.06.004_bib0185","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis (VITAL and FungiScope Investigators)","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.riam.2026.06.004_bib0190","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.eimc.2013.02.002","article-title":"Epidemiolog\u00eda y prevenci\u00f3n de las infecciones nosocomiales causadas por hongos filamentosos y levaduras","volume":"31","author":"Pem\u00e1n","year":"2013","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.riam.2026.06.004_bib0195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.riam.2021.04.004","article-title":"Antif\u00fangicos de uso sist\u00e9mico","volume":"38","author":"Quiles-Melero","year":"2021","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.riam.2026.06.004_bib0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/8755122519859976","article-title":"Adherence to antifungal guidelines in malignant hematology: literature review","volume":"35","author":"Reslan","year":"2019","journal-title":"J Pharm Technol"},{"key":"10.1016\/j.riam.2026.06.004_bib0205","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.eimc.2009.04.001","article-title":"Antifungals for systemic use","volume":"27","author":"Ruiz-Camps","year":"2009","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.riam.2026.06.004_bib0210","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2147\/TCRM.S90335","article-title":"Role of isavuconazole in invasive fungal infections","volume":"12","author":"Wilson","year":"2016","journal-title":"Ther Clin Risk Manag"}],"container-title":["Revista Iberoamericana de Micolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140626000392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140626000392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:28:06Z","timestamp":1790137686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130140626000392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":21,"alternative-id":["S1130140626000392"],"URL":"https:\/\/doi.org\/10.1016\/j.riam.2026.06.004","relation":{},"ISSN":["1130-1406"],"issn-type":[{"value":"1130-1406","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isavuconazole utilization in a Spanish tertiary hospital","name":"articletitle","label":"Article Title"},{"value":"Revista Iberoamericana de Micolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.riam.2026.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Asociaci\u00f3n Espa\u00f1ola de Micolog\u00eda.","name":"copyright","label":"Copyright"}]}}